Ribociclib plus Endocrine Therapy in Early Breast Cancer

Ian F. Tannock; Tomer Meirson; Antonio Fojo

doi:10.1056/nejmc2404917

Ribociclib plus Endocrine Therapy in Early Breast Cancer

Ian F. Tannock
, Tomer Meirson
, Antonio Fojo

University Health Network
Davidoff Cancer Center
Columbia University

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	2220-2221
Number of pages	2
Journal	New England Journal of Medicine
Volume	390
Issue number	23
DOIs	https://doi.org/10.1056/nejmc2404917
State	Published - 20 Jun 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/nejmc2404917

Cite this

@article{d65cc691e3234a5f8a2121920f6024e6,

title = "Ribociclib plus Endocrine Therapy in Early Breast Cancer",

author = "Tannock, \{Ian F.\} and Tomer Meirson and Antonio Fojo",

year = "2024",

month = jun,

day = "20",

doi = "10.1056/nejmc2404917",

language = "אנגלית",

volume = "390",

pages = "2220--2221",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

TY - JOUR

T1 - Ribociclib plus Endocrine Therapy in Early Breast Cancer

AU - Tannock, Ian F.

AU - Meirson, Tomer

AU - Fojo, Antonio

PY - 2024/6/20

Y1 - 2024/6/20

UR - https://www.scopus.com/pages/publications/85196695208

U2 - 10.1056/nejmc2404917

DO - 10.1056/nejmc2404917

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 38899706

AN - SCOPUS:85196695208

SN - 0028-4793

VL - 390

SP - 2220

EP - 2221

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 23

ER -

Ribociclib plus Endocrine Therapy in Early Breast Cancer

UN SDGs

Access to Document

Other files and links

Cite this